- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/01 - DNA viruses
Patent holdings for IPC class C07K 14/01
Total number of patents in this class: 317
10-year publication summary
|
5
|
13
|
11
|
11
|
10
|
20
|
11
|
27
|
14
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Flagship Pioneering Innovations V, Inc. | 224 |
9 |
| Deutsches Krebsforschungszentrum | 415 |
6 |
| The University of North Carolina at Chapel Hill | 2062 |
6 |
| The Institute of Biophysics of The Chinese Academy of Sciences | 11 |
6 |
| Guangdong Lanyu Biotechnology Co., Ltd. | 6 |
6 |
| ContraFect Corporation | 70 |
5 |
| The General Hospital Corporation | 4792 |
4 |
| Kaneka Corporation | 4600 |
4 |
| Mitsui & Co., Ltd. | 56 |
4 |
| Proclara Biosciences, Inc. | 8 |
4 |
| Rakuno Gakuen University | 15 |
4 |
| Boehringer Ingelheim Vetmedica, Inc. | 111 |
3 |
| The Johns Hopkins University | 5739 |
3 |
| EpiVax, Inc. | 81 |
3 |
| NeuroPhage Pharmaceuticals, Inc. | 5 |
3 |
| The University of Tokyo | 4244 |
3 |
| Massey Ventures Limited | 14 |
3 |
| Othair Prothena Limited | 30 |
3 |
| The Regents of the University of California | 20230 |
2 |
| Genentech, Inc. | 4008 |
2 |
| Other owners | 234 |